(Q36307484)

13 August 2017

1 reference

title

Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction (English)

1 reference

13 August 2017

7

Francesco Montorsi

1 reference

13 August 2017

1

Alberto Briganti

1 reference

13 August 2017

2

Andrea Salonia

1 reference

13 August 2017

6

Patrizio Rigatti

1 reference

13 August 2017

4

Giuseppe Zanni

1 reference

13 August 2017

3

Federico Deho'

1 reference

13 August 2017

Luigi Barbieri

5

1 reference

13 August 2017

5 November 2005

1 reference

13 August 2017

World Journal of Urology

1 reference

13 August 2017

23

1 reference

13 August 2017

6

1 reference

13 August 2017

374-384

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-005-0022-6

13 August 2017

0 references

cites work

Involvement of nitric oxide in the non-adrenergic non-cholinergic neurotransmission of horse deep penile arteries: role of charybdotoxin-sensitive K(+)-channels.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00345-005-0022-6

Time course of the interaction between tadalafil and nitrates

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00345-005-0022-6

Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection

21 January 2018

1 reference

12 December 2020

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

1 reference

12 December 2020

Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit

1 reference

12 December 2020

A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction

1 reference

12 December 2020

Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients

1 reference

12 December 2020

Efficacy of vardenafil in men with erectile dysfunction: a flexible-dose community practice study

1 reference

12 December 2020

Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure

1 reference

12 December 2020

The efficacy of sildenafil citrate (Viagra) in clinical populations: an update

1 reference

12 December 2020

In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions

1 reference

12 December 2020

Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire

1 reference

12 December 2020

Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis.

1 reference

12 December 2020

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction

1 reference

12 December 2020

Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus

1 reference

12 December 2020

Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age.

1 reference

12 December 2020

EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction

1 reference

12 December 2020

Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.

1 reference

12 December 2020

Effects of tadalafil on erectile dysfunction in men with diabetes

1 reference

12 December 2020

Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum

1 reference

12 December 2020

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

1 reference

12 December 2020

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial

1 reference

12 December 2020

Sildenafil treatment of serotonin reuptake inhibitor-induced sexual dysfunction

1 reference

12 December 2020

Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

1 reference

12 December 2020

Sildenafil: clinical toxicology profile

1 reference

12 December 2020

Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction

1 reference

12 December 2020

The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia

1 reference

12 December 2020

Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction.

1 reference

12 December 2020

New directions for erectile dysfunction therapies

1 reference

12 December 2020

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

1 reference

12 December 2020

Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic Prostatectomy

1 reference

12 December 2020

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses

1 reference

12 December 2020

Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose

1 reference

12 December 2020

Vardenafil in patients with erectile dysfunction: achieving treatment optimization

1 reference

12 December 2020

Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones.

1 reference

12 December 2020

The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European men.

1 reference

12 December 2020

Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk

1 reference

12 December 2020

Sildenafil for male erectile dysfunction: a systematic review and meta-analysis

1 reference

12 December 2020

Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial

1 reference

12 December 2020

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

12 December 2020

Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy

1 reference

12 December 2020

Vardenafil provides reliable efficacy over time in men with erectile dysfunction

1 reference

12 December 2020

Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

1 reference

12 December 2020

Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A

1 reference

12 December 2020

An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries

1 reference

12 December 2020

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

1 reference

12 December 2020

Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies

1 reference

12 December 2020

Sildenafil citrate for SSRI-induced sexual side effects

1 reference

12 December 2020

A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction

1 reference

12 December 2020

Pharmacology of erectile function and dysfunction

1 reference

12 December 2020

A 4-year update on the safety of sildenafil citrate (Viagra).

1 reference

12 December 2020

Gene expression of the phosphodiesterases 3A and 5A in human corpus cavernosum penis

1 reference

12 December 2020

Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction

1 reference

12 December 2020

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies

1 reference

12 December 2020

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

12 December 2020

Sildenafil (Viagra) for male erectile dysfunction: a meta-analysis of clinical trial reports

1 reference

12 December 2020

The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.

1 reference

12 December 2020

A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle

1 reference

12 December 2020

Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial

1 reference

12 December 2020

Molecular mechanisms for the regulation of penile smooth muscle contractility

1 reference

12 December 2020

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

1 reference

12 December 2020

Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis

1 reference

12 December 2020

10.1007/S00345-005-0022-6

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16273417